Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Neutropenia 1Infections 1

Interventions

Filgrastim 7plerixafor 2Etoposide 2Cyclosporine 2Cyclophosphamide 2pegfilgrastim 1ixabepilone 1Voriconazole 1Vincristine 1Tretinoin 1Topotecan 1Thioguanine 1Radiotherapy 1Psychiatric Rehabilitation 1Phenobarbital 1Peripheral Blood Stem Cell Transplantation 1Mitoxantrone 1Levofloxacin 1Lenalidomide 1Irinotecan 1Ifosfamide 1Idarubicin 1Granulocyte-Macrophage Colony-Stimulating Factor 1Granulocyte Colony-Stimulating Factor 1Doxorubicin 1Daunorubicin 1Cytarabine 1Clofarabine 1Ciprofloxacin 1Cefepime 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Neutropenia × Anidulafungin × Clear all
NCT00068471 2013-06-19

Anidulafungin in Treating Immunocompromised Children With Neutropenia

National Cancer Institute (NCI)

Phase 1/2 Completed

Infections, Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡